Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| André Remans | M | - |
SEPS Pharma NV
 SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium. | 17 years |
| Timothy S. Oostdyk | M | - |
Amatsigroup SAS
 Amatsigroup SAS BiotechnologyHealth Technology Amatsigroup SASU provides human and veterinary drug development services. It offers bio services, pharmaceutical analysis solutions, formulation development, and manufacturing and clinical trial supply packaging and logistics. The company was founded on October 12, 2010 and is headquartered in Fontenilles, France. | - |
| Johan de Turck | M | - |
SEPS Pharma NV
SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium. | - |
| Nico Vandervelpen | M | 49 |
SEPS Pharma NV
SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium. | - |
| Kris Motmans | M | - |
SEPS Pharma NV
SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium. | - |
| Véronique Delord | F | - |
Amatsigroup SAS
Amatsigroup SAS BiotechnologyHealth Technology Amatsigroup SASU provides human and veterinary drug development services. It offers bio services, pharmaceutical analysis solutions, formulation development, and manufacturing and clinical trial supply packaging and logistics. The company was founded on October 12, 2010 and is headquartered in Fontenilles, France. | - |
| Claire Berger | F | - |
Eurofins Amatsigroup NV
 Eurofins Amatsigroup NV BiotechnologyHealth Technology Part of Eurofins Scientific SE, Eurofins Amatsigroup NV engages in the development of biological drugs. The company is based in Ghent, Belgium. The Belgian company was founded in 2007. The CEO is Yves Gonnissen. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Koen Vervaeke | M | - |
Université Catholique de Louvain
| 5 years |
| Nicolas Roberti de Winghe | M | - |
Université Catholique de Louvain
| 5 years |
| Bram de Muer | M | - |
Université Catholique de Louvain
| 3 years |
| Wim Claes | M | - |
Université Catholique de Louvain
| 3 years |
| Dieter Penninckx | M | - |
Université Catholique de Louvain
| 1 years |
| Tine de Ryck | F | 43 |
Université Catholique de Louvain
| 4 years |
| Roger Leyssens | M | - |
SEPS Pharma NV
SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium. | - |
| John Eric F. P. C. Bertrand | M | 46 |
Université Catholique de Louvain
| 1 years |
| Ann-Pascale Bijnens | M | - |
SEPS Pharma NV
SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium. | - |
| Johan Camp | M | 44 |
Université Catholique de Louvain
| 1 years |
| Alexia Bertrand | F | 45 |
Université Catholique de Louvain
| 3 years |
| Quentin Adam | M | - |
Université Catholique de Louvain
| 5 years |
| Bernardo Bortolotti | M | 56 |
Université Catholique de Louvain
| 3 years |
| Serge de Bock | M | - |
Université Catholique de Louvain
| 4 years |
| Thomas Ykman | M | - |
Université Catholique de Louvain
| 4 years |
| Olivier Banneux | M | - |
Université Catholique de Louvain
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Belgium | 21 | 91.30% |
| France | 2 | 8.70% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Yves Gonnissen
- Personal Network
